The impact of self- and physician-administered cancer treatment on work productivity and healthcare utilization
| Autor: | Melissa A. Frasco, Emma van Eijndhoven, Steve Sison, Seth A. Seabury, Christopher Zacker |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male 0301 basic medicine medicine.medical_specialty Lung Neoplasms Alternative medicine Pharmaceutical Science Breast Neoplasms Self Administration Efficiency Pharmacy Disease 03 medical and health sciences 0302 clinical medicine Breast cancer Physicians Absenteeism Health care medicine Humans Productivity Work Performance Work productivity business.industry Cancer Middle Aged Patient Acceptance of Health Care medicine.disease 030104 developmental biology 030220 oncology & carcinogenesis Emergency medicine Physical therapy Female business |
| Zdroj: | Research in Social and Administrative Pharmacy. 14:434-440 |
| ISSN: | 1551-7411 |
| DOI: | 10.1016/j.sapharm.2017.05.009 |
| Popis: | Background Lost productivity in the workplace represents a significant portion of the economic burden of cancer in the United States. Cancer treatments have historically been physician-administered, while recent innovations have led to the development of self-administered, usually oral, agents. Self-administered treatments have the potential to reduce healthcare utilization and time away from work, but the magnitude of these effects is unknown. Objective To compare the effects of self- and physician-administered cancer treatment on work productivity and health care utilization. Methods Cancer subtypes with self- and physician-administered treatment options were selected. Patients with female breast, or lung or bronchus cancer diagnosed in 2004–2013 were identified in the Truven Health Analytics Commercial Claims and Encounters and Health and Productivity Management databases. Using multivariate regression models, work productivity and healthcare utilization were compared for patients receiving self- versus physician-administered treatment in the 12 months after initial diagnosis. Work productivity outcomes included the number of sick days and short-term disability claims. Results One month of self- versus physician-administered treatment significantly reduced cancer-related outpatient services, doctor visits, and infusions in the 12 months after initial diagnosis for both cancers of interest. In addition, breast and lung or bronchus cancer patients who received self-administered treatment were less likely to have short-term disability claims, and breast cancer patients with non-metastatic disease who received self-administered treatment had significantly fewer sick days. Conclusions Self-administered cancer treatment was associated with fewer cancer-related outpatient services and reduced time away from work compared to physician-administered cancer treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect